NIST Now "King of the Hill" on Cyber Standards
Client Alert | 1 min read | 05.14.13
Following its key cyber role in President Obama's Executive Order No. 13636 issued this February, the National Institute of Standards and Technology (NIST) again seized the reins on federal cybersecurity standards on April 30, issuing the 457-page tome, Security and Privacy Controls for Federal information Systems and Organizations, that not only provides the "most comprehensive update" of the core information security controls, but also cuts new ground for cybersecurity standards governing mobile and cloud computing technology, applications security, supply chain protection, advanced persistent threats, and privacy controls for federal agencies and contractors. While some critics have sought to brush back prior NIST standards as too voluminous and technically dense, this latest publication underscores NIST's increasing dominance over cyber standards, as shown by both DoD and the Office of the Director of National Intelligence embracing this NIST update, thus paving the way for federal agencies to flow down new and expanded security standards to government contractors consistent with the executive order's directive to the FAR Council.
Contacts
Insights
Client Alert | 4 min read | 09.16.26
CMS Offers Guidance as Scrutiny Rises Over ABA Therapy in Medicaid
Between 2021 and 2025, Medicaid spending on ABA therapy grew six times faster than the number of children who received services, making it one of the fastest-growing areas of Medicaid expenditure, according to CMS. On August 4, 2026, CMS released a toolkit to help state Medicaid and CHIP agencies strengthen their programs and limit fraud, waste, and abuse tied to increased demand for ABA therapy. In 2025, Medicaid spent about $10 billion on ABA and related therapy services for children with ASD — a dramatic increase from the $2 billion spent in 2021.
Client Alert | 4 min read | 09.15.26
GAO Indicates Reasonable Conflict of Interest Investigation Must Include Inquiry of Involved Firm
Client Alert | 3 min read | 09.15.26
Client Alert | 7 min read | 09.14.26
AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

